PURPOSE: Proton doses are sensitive to intra- and interfractional anatomic changes. We analyzed the effects of interfractional anatomic changes in doses to lung tumors treated with proton therapy. METHODS AND MATERIALS: Weekly four-dimensional computed tomography (4D-CT) scans were acquired for 8 patients with mobile Stage III non-small cell lung cancer who were actually treated with intensity-modulated photon radiotherapy. A conformal proton therapy passive scattering plan was designed for each patient. Dose distributions were recalculated at end-inspiration and end-expiration breathing phases on each weekly 4D-CT data set using the same plans with alignment based on bone registration. RESULTS: Clinical target volume (CTV) coverage was compromised (from 99% to 90.9%) in 1 patient because of anatomic changes and motion pattern variation. For the rest of the patients, the mean CTV coverage on the repeated weekly 4D-CT data sets was 98.4%, compared with 99% for the original plans. For all 8 patients, however, a mean 4% increase in the volume of the contralateral lung receiving a dose of at least 5 Gy (V5) and a mean 4.4-Gy increase in the spinal cord maximum dose was observed in the repeated 4D-CT data sets. A strong correlation between the CTV density change resulting from tumor shrinkage or anatomic variations and mean contralateral lung dose was observed. CONCLUSIONS: Adaptive re-planning during proton therapy may be indicated in selected patients with non-small cell lung cancer. For most patients, however, CTV coverage is adequate if tumor motion is taken into consideration in the original simulation and planning processes.
PURPOSE: Proton doses are sensitive to intra- and interfractional anatomic changes. We analyzed the effects of interfractional anatomic changes in doses to lung tumors treated with proton therapy. METHODS AND MATERIALS: Weekly four-dimensional computed tomography (4D-CT) scans were acquired for 8 patients with mobile Stage III non-small cell lung cancer who were actually treated with intensity-modulated photon radiotherapy. A conformal proton therapy passive scattering plan was designed for each patient. Dose distributions were recalculated at end-inspiration and end-expiration breathing phases on each weekly 4D-CT data set using the same plans with alignment based on bone registration. RESULTS: Clinical target volume (CTV) coverage was compromised (from 99% to 90.9%) in 1 patient because of anatomic changes and motion pattern variation. For the rest of the patients, the mean CTV coverage on the repeated weekly 4D-CT data sets was 98.4%, compared with 99% for the original plans. For all 8 patients, however, a mean 4% increase in the volume of the contralateral lung receiving a dose of at least 5 Gy (V5) and a mean 4.4-Gy increase in the spinal cord maximum dose was observed in the repeated 4D-CT data sets. A strong correlation between the CTV density change resulting from tumor shrinkage or anatomic variations and mean contralateral lung dose was observed. CONCLUSIONS: Adaptive re-planning during proton therapy may be indicated in selected patients with non-small cell lung cancer. For most patients, however, CTV coverage is adequate if tumor motion is taken into consideration in the original simulation and planning processes.
Authors: P Giraud; M Antoine; A Larrouy; B Milleron; P Callard; Y De Rycke; M F Carette; J C Rosenwald; J M Cosset; M Housset; E Touboul Journal: Int J Radiat Oncol Biol Phys Date: 2000-11-01 Impact factor: 7.038
Authors: H Helen Liu; Peter Balter; Teresa Tutt; Bum Choi; Joy Zhang; Catherine Wang; Melinda Chi; Dershan Luo; Tinsu Pan; Sandeep Hunjan; George Starkschall; Isaac Rosen; Karl Prado; Zhongxing Liao; Joe Chang; Ritsuko Komaki; James D Cox; Radhe Mohan; Lei Dong Journal: Int J Radiat Oncol Biol Phys Date: 2007-03-29 Impact factor: 7.038
Authors: Joe Y Chang; Lei Dong; Helen Liu; George Starkschall; Peter Balter; Radhe Mohan; Zhongxing Liao; James D Cox; Ritsuko Komaki Journal: J Thorac Oncol Date: 2008-02 Impact factor: 15.609
Authors: Jingya Wang; Steven H Lin; Lei Dong; Peter Balter; Radhe Mohan; Ritsuko Komaki; James D Cox; George Starkschall Journal: Int J Radiat Oncol Biol Phys Date: 2012-03-21 Impact factor: 7.038
Authors: Charles B Simone; David Ly; Tu D Dan; John Ondos; Holly Ning; Arnaud Belard; John O'Connell; Robert W Miller; Nicole L Simone Journal: Radiother Oncol Date: 2011-06-12 Impact factor: 6.280
Authors: Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan Journal: Transl Lung Cancer Res Date: 2017-04